Editorial: UK private drug payments – a can of worms for the pharma industry
This article was originally published in Scrip
Executive Summary
Last week Alan Johnson, the UK's health secretary, sparked controversy after announcing that National Health Servicepatients would be able to buy medicines privately without forfeiting their right to state-funded treatment.